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Flow  cytometry  was  used  to identify  mAbs  that  recognize  conserved  epitopes  on  hamster  leukocyte  dif-
ferentiation  molecules  (hLDM)  and  also  to characterize  mAbs  developed  against  hLDM.  Initial  screening
of  mAbs  developed  against  LDMs  in  other  species  yielded  mAbs  speciﬁc  for  the  major  histocompatibility
(MHC)  II molecule,  CD4  and  CD18.  Screening  of  sets of mAbs  developed  against  hLDM  yielded  22 new
mAbs,  including  additional  mAbs  to  MHC  II molecules  and  mAbs  that recognize  LDMs  expressed  on  all
leukocytes,  granulocytes,  all lymphocytes,  all T  cells,  a subset  of T cells,  or on  all  B cells.  Based  on com-
parison  of  the  pattern  of  expression  of  LDMs  expressed  on  all hamster  leukocytes  with  the  patterns  oflow cytometry
D4
D8
expression  of  known  LDMs  in  other  species,  as  detected  by ﬂow  cytometry  (FC),  four  mAbs  are  predicted
to  recognize  CD11a,  CD44, and  CD45.  Cross  comparison  of  mAbs  speciﬁc  for a subset of hamster  T  cells
with  a cross  reactive  mAb  known  to recognize  CD4  in mice  and  one  recognising  CD8  revealed  they  rec-
ognize  CD4.  The  characterization  of these  mAbs  expands  opportunities  to use  hamsters  as  an additional
model  species  to investigate  the mechanisms  of immunopathogenesis  of  infectious  diseases.
© 2016  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license. Introduction
The golden or Syrian hamster (Mesocricetus auratus) is used in
iomedical research as a model for human and other animal dis-
ases where the mouse is not appropriate. It is used as a model in
ultiple infectious diseases studies including Nipah virus (Wong
t al., 2003), Hanta virus (Hammerbeck and Hooper, 2011), Clostrid-
um difﬁcile (Goulding et al., 2009) and safety testing of leptospirosis
accines (Haake, 2006) and reviewed in Golden et al. (2015a,b). Of
articular interest to us is its usefulness as a small animal model
or research into malignant catarrhal fever in ruminants (Buxton
t al., 1988; Jacoby et al., 1988; Russell et al., 2009). Hamsters offer
n opportunity for adoptive cell transfer experiments to explore
athogenesis, as they are highly inbred (Campbell et al., 1996).
his may  be attributable to the current lineage being derived from
hree siblings caught in 1930 limiting genetic heterogeneity and
unctionality (Phillips et al., 1981).
The usefulness of the hamster as a small animal model for
iomedical research has been constrained by a lack of immunologi-
al reagents to detect LDM differentially expressed on lymphoid cell
ubsets. Of the few monoclonal antibodies (mAbs) speciﬁc for ham-
∗ Corresponding author.
E-mail address: david.haig@nottingham.ac.uk (D. Haig).
ttp://dx.doi.org/10.1016/j.vetimm.2016.12.003
165-2427/© 2016 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
ster leukocyte differentiation molecules (hLDM) that have been
developed, most are no longer available (Liu et al., 1991; Witte
et al., 1985; Witte and Streilein, 1983a,b; Witte and Streilein, 1986).
More recently the Washington State University Monoclonal Anti-
body Centre has addressed the growing need for reagents for use
with this species. The reagents developed thus far have only been
partially characterized.
The objective of the study presented here has been to com-
plete the initial characterization of mAbs produced by the Centre
and screen a selected set of commercially available mAbs for cross
reactivity with hLDMs. These mAbs are available to the research
community for further detailed characterisation.
2. Materials and methods
2.1. Animals
Spleen, lymph node and blood from disease-free Syrian ham-
sters of variable age and either sex were obtained from Harlan
Laboratories (Loughborough, U.K.) and Charles River Laboratories,
(San Diego, CA). Additional animals were obtained from a breeding-
colony maintained at WSU. Ethical approval for the work was
obtained from site ethical review committees at both WSU  and the
SVMS, University of Nottingham. The Nottingham ethical review
was performed by the local animal welfare and ethical review body
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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AWERB) and the work performed under ASPA (UK) project license
003214 belonging to D. Haig.
.2. Antibodies used in this study
The antibodies used in this study are shown in Table 1. The mAbs
ere developed from mice immunized with hamster peripheral
lood leukocytes (HAB), thymocytes (HAT), lymph node mononu-
lear cells (HAL), or a mixture of non-adherent and adherent
ononuclear splenocytes (HASA) (Davis et al., 1987; McNees et al.,
009). Additional mAbs screened for cross reactivity to hLDMs
ere from commercial sources and the WSU  Monoclonal Anti-
ody Centre http://vmp.vetmed.wsu.edu/resources/monoclonal-
ntibody-center
.3. Tissue collection and preparation
Blood was  collected into 10% lithium heparin or acid citrate
extrose (ACD). Spleen (Spln) and mesenteric lymph nodes (MLN)
ere removed and placed into PBS. Mononuclear cell suspensions
ere prepared by either lymphoprep (Nycomed, Pharmacia, Oslo,
orway), or ammonium chloride − potassium cell lysis buffer (ACK,
ibco Life Sciences, U.K.), which retains both MNC  and granulo-
ytes. To obtain enough cells for each experiment, spleen and MLN
NCs were pooled.
.4. Flow cytometry
Two methods were used to process cells for ﬂow cytometry.
lood was collected in acid citrate dextrose (ACD) and used at 50 l
ith 50 l of mAb  in tissue culture medium or in ascites (15 g/ml)
n 15 ml  centrifuge tubes. Following 15 min  of incubation on ice, the
ells were sedimented by centrifugation and re-suspended in 10 ml
f PBS containing 0.5% horse serum (PBSh). Following removal of
able 1
onoclonal antibodies (WSU Monoclonal Antibody Centre) and Speciﬁcities.
mAb Ig isotype Putative spe
H42A IgG2a MHC  II 
BAQ30A IgG1 CD18 
HAL4A  IgG3 MHC  class I
HAL16A IgG1 MHC  class I
HAB2A IgG1 T 
HAL26A IgG1 T 
HAT19A G2a T 
HAT24A IgG1 T 
HAB1A IgG1 T subpopula
HAL36A IgG2a T subpopula
HAL9A IgG1 B 
HAL11A IgG1 B 
HAL14A IgG2b B 
HAL17A IgG2a B 
HASA7A IgG1 B 
HAB6B IgG2a Pan lympho
(+monocyte
HASA18A IgM Pan lympho
(+monocyte
HASA25A IgG1 CD45 predic
HAT13A IgG2b CD45 predic
HAT7A IgG2a CD44 predic
HAT16A IgG2b CD11a pred
HAB3A IgG1 Pan leukocy
HASA26B IgG1 Granulocyte
egend:
1 Based on labelling characteristics of lymphocyte, monocyte and granulocyte-enriche
I  positive and negative fractions of the leukocytes.
2 Proposed speciﬁcities based on two  colour comparisons of MNC  (PBMC or spleen/M
Ab  (GK1.5 anti-CD4). For the frequency ranges of the phenotyped cells, six different MNC
ere  tested at the same time (n = 3 or 4). This is why the% frequencies of HAB2A, HAL 2
d  = not determined. These mabs are listed as they are available for further characterisatimmunopathology 183 (2017) 40–44 41
the PBSh, the cells were labelled with R-phycoerythrin (PE) or ﬂu-
orescein conjugated isotype speciﬁc second step goat anti-mouse
IgG1, IgG2a, IgG2b, IgG3 or IgM antibody (Invitrogen, Carlsbad, CA,
USA) alone or in combination to determine speciﬁcity. The rbc were
lysed with Becton Dickinson ﬁx/lyse solution (BD, Oxford, UK) re-
sedimented and then re-suspended in 2% paraformaldehyde in PBS.
When using the cross reactive mAbs that recognize epitopes con-
served on hamster CD4 and CD8 T cells, a ﬂuorescein conjugated
goat mouse-absorbed anti-rat IgG second step was used for rat
GK1.5 IgG2b mAb. A PE conjugated 341 IgG1 was  used with HAB1A
IgG1 labelled with ﬂuorescein conjugated anti-IgG1 Zenon reagent
(Invitrogen, Carlsbad, CA, USA).
For the second method, cells in RPMI-1640 with 2% FBS or PBS
with 2% FBS were distributed into 96 well culture plates (2 × 105 to
1 × 106 cells per well). 50 l of appropriately diluted primary anti-
bodies were added to the cells. Following incubation for 30 min
(4 ◦C) the plates were centrifuged at 2000 rpm for 2 min  and the
supernatant removed. The cells were washed twice and incubated
alone or in combination with isotype speciﬁc goat anti-mouse IgG
or goat anti-rat IgG antibodies conjugated with ﬂuorescein, PE or
allophycocyanine (APC). In some experiments whole blood was
incubated with mAbs and then the rbc were removed using 1 x
BD FACSTM lysing solution before continuing with the labelling
process. A Becton Dickinson FACS Calibur (Immunocytometry Sys-
tems, San Jose, CA, USA) (WSU) and Beckman Coulter EPICS Altra,
FC500 and MoFlo XDP (School of Molecular Medical Sciences in the
Queen’s Medical Centre, Nottingham, UK) were used to collect data.
Data were analysed with FCS Express, LA, USA and the Beckman
Coulter programs.
For ﬂow cytometric analysis (FC), three electronic gates were
used to identify and colour code regions of a dot plot display in
side (SSC) vs forward light scatter (FSC) containing lymphocytes
(L, orange), predominantly monocytes (M,  blue), and granulocytes
ciﬁcity1 Speciﬁcity and% of cells2
MHC  II, 48%
CD18, 100%
I MHC  class II, 50%
I MHC  class II, 50%
33%–43% (CD4 included)
42%–63% (CD4 included)
39–53% (CD4 included)
53%–73%
tion 12–44% (CD4)
tion 16–42% (CD4)
n.d.
n.d.
B 23%
n.d.
34–49% not CD4
cyte
 subset?)
n.d.
cyte
 subset?)
n.d.
ted n.d.
ted CD45
ted n.d.
icted n.d.
te >95% incl CD4 and CD?
 + n.d.
d fractions of whole blood leukocytes and 2-colour FC comparison with MHC  class
LN MNC) labelling by the mAbs compared to each other and a deﬁned CD-speciﬁc
 samples from different hamsters were used for the analyses, but not all antibodies
6A and HAT19A have different ranges, in spite of recognising the same molecule.
on by the research community.
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Fig. 1. Hamster blood leukocytes. (Fig. 1A) The major populations of cells were visualized by side vs forward light scatter, dot plot and colour coded for cell subsets:
orange  = lymphocytes (L), blue = monocytes (M), red = granulocytes (G). It should be noted that gating for monocytes may include large lymphocytes. There is no distinct
border separating lymphocytes from monocytes. (Fig. 1B) Example of cells incubated with a mixture of anti-IgG1, IgG2a, and IgG2b 2nd step reagents alone to show there
was  no background attributed to nonspeciﬁc labelling and the relative position of colour coded granulocytes, monocytes, and lymphocytes visualized in side scatter vs
ﬂuorescence. (Fig. 1C) Typical pattern of labelling with mAbs speciﬁc for MHC  II cross species for humans, cattle, goats, sheep, and llama/alpaca. (Fig. 1D) Typical pattern of
labelling with mAbs speciﬁc for CD18 cross species for human, cattle, goats, sheep, llama/alpaca, horse, dogs, and cats. (Fig. 1E) Unique pattern of expression of a mAb-deﬁned
molecule on all lymphocytes and apparent expression on a subset of monocytes. (Fig. 1F) Expression of a mAb-deﬁned molecule on granulocytes (Background labelling of
lymphocytes is attributable to cross reactive anti-IgM antibody present in the 2nd step reagent used in these studies). (Fig. 1G) Typical pattern of labelling with mAbs speciﬁc
for  CD45 cross species in humans, cattle, goats, sheep, llama/alpaca, rabbit. (Fig. 1H) Pattern of labelling similar to CD11a cross species in humans, cattle, goats, sheep, rabbit.
(Fig. 1I) Pattern of labelling similar to CD44 cross species in humans, cattle, goats, sheep, horse, rabbits. (Fig, 1J) Pattern of labelling with no apparent match to known LDMs.
It  should be noted that multiple hamsters were used at WSU  during the past 28 years to develop and characterize the mAbs described in this report. On some occasions,
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epresentative ﬂow cytometric proﬁles were selected from different data sets for p
eader is referred to the web version of this article.)
G, red) to track the different cell populations in SSC vs FL and in 2
olour combinations (Fig. 1 A and B) (Allen et al., 2009).
. Results and discussion
Flow cytometry was used to screen for mAbs that recognize
onserved epitopes expressed on hLDM (Saalmüller et al., 2005).
wo ruminant cell-speciﬁc mAbs recognized conserved epitopes
n hamster MHC  II (H42A) (Davis et al., 1987) and CD18 (BAQ30A)
Naessens and Howard, 1993) (Table 1 and Fig. 1C and D respec-
ively). As shown in Figs. 1 and 2 and summarized in Table 1, mAbs
ould be grouped and clustered according to unique patterns of
xpression of the mAb-deﬁned molecules. By comparing their pat-
erns of expression with that of H42A (MHC II, expressed on B
ells and monocytes) it was possible to distinguish mAbs speciﬁc
or MHC  II, T cells and B cells. MAbs speciﬁc for MHC  II yielded
 diagonal pattern of expression, indicating the mAbs recognized
ig. 2. Hamster blood leukocytes after 2 colour labelling. (Fig. 2A) Representative plot FL-
abelling with anti-IgG1, IgG2a 2nd step reagents. (Fig. 2B) Comparison of H42A (speciﬁc
ecognizes MHC II. (Fig. 2C) Comparison of labelling H42A with HAL26A showed HAL26A re
 molecule expressed on T cells. (Fig. 2D) Comparison of HA19A with HAB2A yielded a 
xpressed on T cells. (Fig. 2E) Comparison of HAT19A with HAL9A showed HAL9A recog
olecule expressed on B cells. (Fig. 2F) Comparison of labelling of HAL17A with HAL11A
 cells, i.e., the pattern of labelling was diffuse, indicating the density of the molecules d
ubset of T cells. (Fig. 2H) A comparison of labelling HAL26A with HAL36A yielded a similar
wo  colour labelling showed HAB1A blocks co-labelling with HAL36A providing further e
erformed multiple times to verify speciﬁcity. Multiple hamsters were used to collect thether occasions, multiple hamsters were used to pool blood for analysis. The best
tation here. (For interpretation of the references to color in this ﬁgure legend, the
epitopes on the same molecule (e.g. HAL16A, Fig. 2 B). MAbs spe-
ciﬁc for T cells distinguished populations of MHC  II negative cells
(e.g. HAL26A, Fig. 2 C) whereas mAbs speciﬁc for B cells distin-
guished a population cells negative for T cells and monocytes (e.g.
HAT19A vs HAL9A Fig. 2 E). Comparison of the mAbs under study
showed 4 mAbs recognized T cells (Table 1). Cross comparison of
the mAbs showed they all recognized the same molecule, as evi-
denced by a diagonal pattern of labelling (e.g. HAT19A and HAB2A,
Fig. 2 D). Two mAbs recognized a molecule expressed on a subset
of T cells (HAB1A and HAL36A, Figs. 2 G and H). Cross comparison
of the mAbs showed they recognized the same molecule. HAB1A
blocked co-labelling with HAL36A. Comparison of the mAbs spe-
ciﬁc for T cells and B cells veriﬁed they were expressed on mutually
exclusive populations (e.g. compare HAL9A and HAT19A, Fig. 2 E).
Further comparison of the mAbs showed 5 mAbs recognized B cells
(Table 1). Cross comparison of the mAbs speciﬁc for B cells showed
they recognized 2 or more different molecules, as exempliﬁed by
2 vs FL-1 of cells incubated with 2nd steps alone to show there was no background
 for MHC II) with HAL16A yielded a diagonal pattern of labelling showing HAL16A
cognized a molecule not expressed on monocytes or B cells, indicating it recognized
diagonal pattern of labelling indicating both mAbs recognized the same molecule
nizes a molecule not expressed on T cells or monocytes, inferring it recognizes a
 showed a pattern of labelling indicating they recognized different molecules on
iffered. (Fig. 2G) Comparison of HAT19A with HAB1A showed HAB1A recognized a
 pattern of labelling, suggesting HAB1A and HAL36A recognized the same molecule.
vidence both of the mAbs recognized the same molecule. Two colour labelling was
 data and to obtain the best representative FC proﬁle.
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Fig. 3. Cross reactive mAbs were used to validate speciﬁcity of HAB1A and HAL36A, a rat anti-mouse CD4 (GK1.5 IgG2b, (Dialynas et al., 1983)) cross reactive with hamster
CD4  and mouse anti-rat CD8 341 (IgG2a) speciﬁc for mouse CD8 (Hammerbeck and Hooper, 2011) showed HAB1A and HA36A recognize the same molecule (labelling only
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ihown for HAL36A, Fig. 3A). Comparison with mAb  341 (mouse anti-rat CD8) sho
he  UK and the US while validating cross reactivity and speciﬁcity.
he pattern of labelling obtained in the comparisons. MAbs recog-
izing different epitopes on the same population of cells exhibit a
iffuse pattern of labelling (e.g. HAL17A and HAL11A Fig. 2F). Anal-
sis of the remaining mAbs showed 2 mAbs recognized a molecule
xpressed on all lymphocytes and a subset of monocytes (HASA18A
nd HAB6B, Table 1 and Fig. 1 E). One mAb  (HASA26B) recognized
 molecule expressed on granulocytes (Fig. 1 F). Additional mAbs
etected molecules expressed on all leukocytes, with speciﬁcities
nd patterns of expression characteristic of known LDM. Compar-
tive studies conducted as part of international workshops during
he 1990s and 2004 and during development of mAbs for use in
lama/alpacas and rabbits, demonstrated patterns of expression of
ome LDMs, as detected by FC analysis using SSC vs ﬂuorescence,
ere identical thus providing a way to predict the speciﬁcity of
Abs under study (Davis et al., 1995; Davis et al., 2007; Davis
nd Hamilton, 2008; Davis et al., 2000; Saalmüller et al., 2005;
avernor et al., 1993; Tumas et al., 1994). Two  mAbs recognized a
olecule with expression characteristic of CD45 in multiple species
HASA25A and HAT13A (Table 1 and Fig. 1 G)), one characteristic of
D11a (HAT16A, Fig. 1 H), and one characteristic of CD44 (HAT7A,
ig. 1 I). The speciﬁcity of one mAb  (HAB3A) could not be predicted
ased on the pattern of expression of the molecule (Fig. 1 J).
Screening of commercial mAbs yielded a mAb  made in rats
gainst mouse CD4 that recognizes a conserved epitope expressed
n hamster CD4 [eBioscience GK1.5 IgG2b (Dialynas et al., 1983)]
nd a mouse anti-rat CD8 mAb  that recognized a conserved epi-
ope on hamster CD8 [Biolegend 341 IgG1 (Hammerbeck and
ooper, 2011)]. Comparison of labelling of GK1.5 and with HAL36A
Fig. 3A) and 341 with HAB1A (Fig. 3B) showed both HAL36A and
AB1A recognized hamster CD4.
. Cross comparison with the anti-CD4 mAbs veriﬁed mAb  341
ross reacts with hamster CD8, ﬁlling in a gap in the reagents devel-
ped for use in hamsters (Fig. 3 D– F).
The development and availability of these 22 new mAbs, along
ith the commercial mAb  number 341 that recognises hamster
D8, greatly expands opportunities to use hamsters in infectious
isease research. In conclusion, the characterisation of mAbs to
amster hLDMs has provided further detail on speciﬁcity, mak-
ng the mAbs more useful for the research community. These areAB1A labels a subset distinct from CD8 (Fig. 3B). Multiple hamsters were used in
now available for further characterisation and use by the research
community.
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